<?xml version="1.0" encoding="UTF-8"?>
<p>Ahn et al. conducted a RCT including 100 patients with different gynecological cancers (cervical, endometrium and ovarian) receiving chemotherapy and 
 <italic>Agaricus blazeii murill</italic> Kyowa or placebo (
 <xref rid="B1" ref-type="bibr">Ahn et al., 2004</xref>). Patients showed improvements in terms of mood parameters (anxiety, depression, mental stability) and body strength compared to placebo on a modified EORTC-QLQ-C30. Between-group differences were not reported.
</p>
